- Home
- ORMP vs VCEL Comparison
ORMP vs VCEL Comparison
Compare ORMP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- VCEL
- Stock Information
- Founded
- ORMP 2002
- VCEL 1989
- Country
- ORMP United States
- VCEL United States
- Employees
- ORMP N/A
- VCEL N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORMP Health Care
- VCEL Health Care
- Exchange
- ORMP Nasdaq
- VCEL Nasdaq
- Market Cap
- ORMP 90.2M
- VCEL 2.1B
- IPO Year
- ORMP N/A
- VCEL 1997
- Fundamental
- Price
- ORMP $2.41
- VCEL $32.18
- Analyst Decision
- ORMP Hold
- VCEL Strong Buy
- Analyst Count
- ORMP 1
- VCEL 6
- Target Price
- ORMP N/A
- VCEL $61.50
- AVG Volume (30 Days)
- ORMP 99.1K
- VCEL 702.2K
- Earning Date
- ORMP 11-06-2025
- VCEL 11-06-2025
- Dividend Yield
- ORMP N/A
- VCEL N/A
- EPS Growth
- ORMP N/A
- VCEL 2045.40
- EPS
- ORMP N/A
- VCEL 0.13
- Revenue
- ORMP $2,000,000.00
- VCEL $249,119,000.00
- Revenue This Year
- ORMP N/A
- VCEL $18.35
- Revenue Next Year
- ORMP N/A
- VCEL $22.47
- P/E Ratio
- ORMP N/A
- VCEL $240.96
- Revenue Growth
- ORMP N/A
- VCEL 16.13
- 52 Week Low
- ORMP $1.82
- VCEL $30.26
- 52 Week High
- ORMP $3.09
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ORMP 71.70
- VCEL 38.67
- Support Level
- ORMP $2.17
- VCEL $30.26
- Resistance Level
- ORMP $2.45
- VCEL $33.92
- Average True Range (ATR)
- ORMP 0.06
- VCEL 1.53
- MACD
- ORMP 0.03
- VCEL -0.19
- Stochastic Oscillator
- ORMP 88.24
- VCEL 27.79
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.